| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 51.433 | 101.413 | 113.732 | 105.404 | 126.556 | 220.362 |
| Total Income - EUR | - | - | - | - | 51.433 | 101.893 | 113.732 | 106.416 | 127.041 | 222.638 |
| Total Expenses - EUR | - | - | - | - | 40.429 | 77.417 | 105.277 | 96.873 | 89.380 | 182.332 |
| Gross Profit/Loss - EUR | - | - | - | - | 11.004 | 24.476 | 8.455 | 9.542 | 37.661 | 40.306 |
| Net Profit/Loss - EUR | - | - | - | - | 10.489 | 23.512 | 7.341 | 8.533 | 36.416 | 35.254 |
| Employees | - | - | - | - | 1 | 2 | 2 | 2 | 1 | 2 |
Check the financial reports for the company - Drx & Lucas S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 13.974 | 26.637 | 14.290 | 5.441 | 947 | 37.438 |
| Current Assets | - | - | - | - | 10.034 | 14.401 | 18.667 | 32.123 | 50.736 | 58.039 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 7.674 | 11.759 | 5.613 | 9.970 | 14.211 | 18.603 |
| Cash | - | - | - | - | 2.360 | 2.641 | 13.055 | 22.153 | 36.525 | 39.436 |
| Shareholders Funds | - | - | - | - | 10.531 | 33.844 | 24.262 | 32.871 | 38.861 | 35.702 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 13.477 | 7.193 | 8.695 | 4.693 | 12.822 | 59.774 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Drx & Lucas S.r.l.